ARCHIVES

Fragmin Cuts Risk Of VE By 50 Percent In Study

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Part One Of A Two-Part Interview With NCI Director Harold Varmus

July 22, 2011

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Cancer Webmasters Seek to Develop Tools for Greater Use of NCI Cancer Information

May 5, 2000

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

MD Anderson Completes $500 Million Research Endowment

September 24, 2010

Cancer Letter Office Moves To Capitol Hill; No Issues Published Next Two Weeks

September 1, 1989